News & Updates
Filter by Specialty:
Is prior allergy a deal-breaker for COVID-19 vacc?
A large prospective, observational study has suggested that while individuals with a history of high-risk allergy may have an increased risk of allergic reactions following receipt of a messenger RNA (mRNA) COVID-19 vaccine, they are still able to receive both vaccine doses.
Is prior allergy a deal-breaker for COVID-19 vacc?
13 Dec 2021
Opioid medication linked to patients’ familiarity, perceptions of efficacy
Use of opioid among adults with knee and/or hip osteoarthritis (OA) often leads to being familiar with the treatment and believing that the medication is beneficial and low-risk, reveals a recent study.
Opioid medication linked to patients’ familiarity, perceptions of efficacy
13 Dec 2021
Can losartan delay the progression of AD?
In individuals with clinically diagnosed mild-to-moderate Alzheimer’s disease (AD), treatment with the angiotensin II receptor blocker (ARB) losartan for 12 months did not reduce the rate of brain atrophy, findings from the phase II RADAR* trial suggest.
Can losartan delay the progression of AD?
13 Dec 2021
Saliva outperforms nasopharyngeal swabs for COVID-19 detection
Compared with nasopharyngeal swabs (NPS), saliva samples provide higher diagnostic yield for detecting positivity to the coronavirus disease 2019 (COVID-19), a recent study has found.
